NFTs and the Art of Drug Development

On this episode, our guest is economist Paul Kohlhaas, co-founder and CEO of Molecule and co-author of the VitaDAO whitepaper. We’ll head to Berlin, Germany, where Paul and his team of scientists, engineers, entrepreneurs and enthusiasts who are designing new ways to advance medicines. In Molecule’s case, they’re using tools not from the lab, but [...]

From Bile to Trial – Ochre Bio

On this episode, Ochre Bio co-founders join us to discuss turning discarded organs into a goldmine of biological insight with deep phenotypics that enables the company to pan for fine-grained expression of all the genes across millions of individual cells from different locations across an organ, and connect those signals to specific disease processes within [...]

By |2021-12-15T16:07:15+00:00October 21, 2021|Uncategorized|0 Comments
Go to Top